This invention is directed to the crystalline potassium salt of a lipoxin Aanalog of Formula (I):processes for preparing the crystalline potassium salts, methods for using them to treat disease-states characterized by inflammation, and pharmaceutical compositions comprising such crystalline potassium salts.